Brief: Prostatype Genomics Q2 EBITDA Loss At SEK 2.4 Mln

Prostatype Genomics AB

18/08/2021 07:11

Aug 18 (Reuters) - Prostatype Genomics AB  PROGEN.ST :
    * Q2 NET SALES AMOUNTED TO 549 TSEK.
    * Q2 EBITDA (EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION,
AND
AMORTIZATION) AMOUNTED TO -2 373 TSEK.

Source text for Eikon:  ID:nWkryrG7 
Further company coverage:  PROGEN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))